Purchase Order 36C25624P0060
- Not listed
- On March 1, 2024, the Department of Veterans Affairs, through Veterans Integrated Service Network 16, awarded a delivery order valued at $235,810.76 to Sofie CO. (doing business as IBA Molecular) for the supply of radioactive positron emission tomography (PET) tracer isotopes to the Medical Center at the Veterans Integrated Service Network 16. This firm-fixed-price delivery order represents pricing year one activity under Indefinite Delivery Contract 36C25624D0046 and is scheduled for completion...
- Sofie CO., operating as IBA Molecular, received a delivery order award valued at $339.6K on January 22, 2026, for radioactive isotopes and positron emission tomography (PET) tracers supporting the Michael E. DeBakey VA Medical Center in Sterling, Virginia. This delivery order, with an ultimate completion date of February 28, 2027, is structured as a firm fixed-price contract with no set-aside designation. The award is issued under a larger indefinite delivery vehicle with VA Veterans...
- This contract was awarded by the Department of Veterans Affairs (VA) Ann Arbor Healthcare System to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The $546,843.12 firm-fixed-price purchase order is for the provision of radioactive isotopes and has a completion date of September 30, 2024. This contract was awarded without a set-aside designation and supports the VA's medical imaging and cancer treatment programs for veterans. Sofie CO. is an established supplier of...
- This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 2 (VISN 2), part of the U.S. Department of Veterans Affairs (VA), to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the provision of emergency radiopharmaceuticals, with a ceiling value of $94,702.70 and a completion date of April 15, 2022. The contract does not have a set-aside designation. Sofie CO. is a specialized manufacturer and supplier of molecular diagnostics and...
- This delivery order, awarded September 1, 2024, represents Option Year 2 of an existing contract vehicle with Sofie CO. (doing business as IBA Molecular), a Sterling, Virginia-based supplier of molecular diagnostics and therapeutic radiopharmaceuticals. The $194,870.88 firm fixed-price delivery order is funded by the Department of Veterans Affairs through Veterans Integrated Service Network 15 and is scheduled for completion by August 31, 2027. This award carries no set-aside designation and...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 10, awarded Sofie CO., operating as IBA Molecular, a $610,725.04 firm fixed-price purchase order on October 1, 2024, for PET MRI radiopharmaceuticals to support the John D. Dingell VA Medical Center in Detroit, Michigan. This award was issued without a set-aside designation following a sole source procurement notice published in September 2024. The VA determined that Sofie CO. was the only vendor capable of...
- This federal contract award to Sofie CO. is for the provision of nuclear medicine PET radioisotopes to the Department of Veterans Affairs (VA) Veterans Health Administration in Veterans Integrated Service Network 21. The $136,876.00 firm-fixed-price purchase order does not have a set-aside designation. Sofie CO. is a for-profit organization that specializes in developing and delivering molecular diagnostics and therapeutics. The company has received numerous federal contract awards from the...
- This contract award to Sofie CO., doing business as Sofie, is for the supply of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The $171,500.00 firm fixed-price purchase order has an ultimate completion date of April 4, 2019 and was awarded on October 1, 2016. This contract is not set aside and is part of Sofie's broader portfolio of federal contracts and indefinite delivery vehicles (IDVs) to supply specialized radiopharmaceuticals, including PET imaging agents and...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA - VHA) awarded a $383,846.78 delivery order contract to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc., to provide PET radiopharmaceuticals. The firm fixed price contract runs from April 15, 2022 to April 15, 2023 and will be performed in Sterling, Virginia. PET radiopharmaceuticals are medical imaging radioisotopes that are used with positron emission...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie. The contract, valued at $690,810.00, is for the supply of FDG-F18 radiopharmaceuticals. Sofie is a subsidiary of Sofie Biosciences, Inc. that specializes in the development and delivery of molecular diagnostics and therapeutics, including radiopharmaceuticals for medical imaging and cancer treatment. The...
The Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16), awarded a $211,476.72 firm fixed-price purchase order to Sofie CO. (doing business as IBA Molecular) on October 1, 2023, for emergency isotopes with a completion date of December 31, 2023. The award carries no set-aside designation and is for performance at the contractor's Sterling, Virginia facility. Sofie CO., a for-profit subsidiary of Sofie Biosciences, Inc., specializes in the development, production, and delivery of molecular diagnostics and therapeutic radiopharmaceuticals, with particular expertise in positron emission tomography (PET) imaging agents used for cancer detection and neurological imaging. The company serves as a critical federal healthcare vendor providing essential radiopharmaceutical products to the VA, Defense Health Agency, and National Institutes of Health. This purchase order represents a discrete emergency procurement within the context of Sofie CO.'s broader portfolio of federal contracts with the VA. The company maintains multiple indefinite delivery vehicles and blanket purchase agreements with various VA VISNs totaling millions of dollars for ongoing PET radiopharmaceutical supply, including products such as PYLARIFY (piflufolastat F-18) for prostate cancer detection, NEURACEQ (florbetaben F-18) for Alzheimer's disease imaging, F-18 fluorodeoxyglucose (FDG) for general oncology imaging, and gallium-68 radiopharmaceuticals. The emergency isotopes procurement reflects the VA's continued reliance on Sofie's specialized capabilities to support diagnostic imaging and cancer treatment programs for veterans across federal medical treatment facilities. The company maintains compliance with U.S. Nuclear Regulatory Commission and Food and Drug Administration licensing requirements while delivering radiopharmaceuticals on both routine and emergency bases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | ($99k) | 4/27/26 | |
| P00001 | Supplemental Agreement for work within scope | $62.5k | 12/22/23 | |
| Not listed | Not listed | $248.4k | 10/17/23 |